Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Ji’an, Jiangxi, China, July 19, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and...
News
Mainz Biomed Appoints Dr. Timothy Wang to Newly Formed Medical Advisory Board
Renowned Experts to Support ColoAlert’s U.S. Pivotal Clinical Trial and Development of Additional Cancer DiagnosticsDr. Wang is the GI (Gastrointestinal)...
Nexstim Receives an NBS System Order from a Finnish Customer
Press release, Helsinki, 19 July 2022 at 10 AM (EET) Nexstim Receives an NBS System Order from a Finnish Customer...
Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023
Bavarian Nordic to supply an additional 1.5 million doses of IMVANEX® vaccine to an undisclosed European countryDeliveries starting in the...
eureKARE launches synthetic biology studio network with inaugural biomedical studio in Belgium
eureKARE launches synthetic biology studio network with inaugural biomedical studio in Belgium Georges Rawadi appointed eureKARE’s Chief of Biotech Studio...
Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION19 July 2022, 07:00 am CEST DSR (Direct Sodium Removal) heart failure drug development: Completed...
Doug Kohrs appointed to Sequana Medical Board of Directors
Highly experienced US medtech leader brings more than 40 years’ experience Ghent, Belgium – 19 July 2022 – Sequana Medical...
Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance
Ad hoc announcement pursuant to Art. 53 LR Q2 sales grew +5% cc1 (-1% USD) Innovative Medicines (IM) sales grew...
180 Life Sciences Corp. Announces $6.5 Million Registered Direct Offering
PALO ALTO, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the...
ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to Grow to $2.46 Billion by 2028
-- Growth to benefit ABVC’s Vitargus medical device product -- FREMONT, CA, July 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire...
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Acer has notified the FDA in the resubmission that the third-party contract packaging manufacturer is ready for inspectionNEWTON, Mass., July...
WIMI Hologram Academy: Vision-based Human-Computer Gesture Interaction Technology in Virtual Reality
HONG KONG, July 18, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility
TUCSON, Ariz., July 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing...
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based PET Tracer [18F]OP-801 at the 2022 Alzheimer’s Association International Conference (AAIC)
– Scientific collaborators at Stanford University will present preclinical data on the sensitivity of OP-801 in comparison to TSPO-PET for...
Ring Therapeutics Announces Three Presentations at the 41st Annual Meeting of the American Society for Virology (ASV)
CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize...
PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
Combination trial to be initiated in Q4 2022CRANBURY, N.J., July 18, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; “PMV...
Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations
New internal manufacturing capabilities to complement existing contract manufacturing relationshipsNEW YORK, July 18, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:...
Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
- Global Phase 2 placebo-controlled trial enrolled twice as fast as the industry average, establishing a roadmap for future studies -...
AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid
Files Complaint in Federal Court to Compel Activist Group to Reveal True Intentions – Including a Potential Hostile Takeover of...
SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022
SANTA CLARA, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving...